Header Logo

Search Results (709)

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.Academic Article Why?
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?Academic Article Why?
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels.Academic Article Why?
Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics.Academic Article Why?
Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications.Academic Article Why?
Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.Academic Article Why?
Trends and outcomes associated with angiotensin-converting enzyme inhibitors.Academic Article Why?
Thompson, PaulPerson Why?
The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.Academic Article Why?
Angiotensin-Converting Enzyme InhibitorsConcept Why?
Cytochrome P-450 Enzyme InhibitorsConcept Why?
Enzyme InhibitorsConcept Why?
Goldberg, RobertPerson Why?
Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.Academic Article Why?
Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.Academic Article Why?
Per Page    Page  of 48last Nextnext
Search Criteria
  • Enzyme Inhibitors
Filter by Type
Click "Why?" to see why an item matched the search.